Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS Research and Therapy
Published in: AIDS Research and Therapy 1/2009

Open Access 01-12-2009 | Short report

Treatment of hypertriglyceridemia and HIV: fenofibrate-induced changes in the expression of chemokine genes in circulating leukocytes

Authors: Carlos Alonso-Villaverde, Gerard Aragonès, Raúl Beltrán-Debón, Laura Fernández-Sender, Anna Rull, Jordi Camps, Josep M Alegret, Jorge Joven

Published in: AIDS Research and Therapy | Issue 1/2009

Login to get access

Abstract

Fenofibrate changed the expression of chemokine genes in circulating leukocytes of HIV-infected patients with hypertriglyceridemia. The data suggest that fenofibrate when effective in the treatment of lipoprotein abnormalities, may act as a modulator of systemic inflammation. This particular action, therefore, may also influence the clinical course of the disease.
Appendix
Available only for authorised users
Literature
1.
Reiche EM, Bonametti AM, Voltarelli JC, Morimoto HK, Watanabe MA: Genetic polymorphisms in the chemokine and chemokine receptors: impact on clinical course and therapy of the human immunodeficiency virus type 1 infection (HIV-1). Curr Med Chem. 2007, 14: 1325-1334. 10.2174/092986707780597934CrossRefPubMed
2.
Depairon M, Chessex S, Sudre P, Rodondi N, Doser N, Chave JP, Riesen W, Nicod P, Darioli R, Telenti A, Mooser V, Swiss HIV Cohort Study: Premature atherosclerosis in HIV-infected individualsfocus on protease inhibitor therapy. AIDS. 2001, 15: 329-334. 10.1097/00002030-200102160-00005CrossRefPubMed
3.
Alonso-Villaverde C, Coll B, Parra S, Montero M, Calvo N, Tous M, Joven J, Masana L: Atherosclerosis in patients infected with HIV is influenced by a mutant monocyte chemoattractant protein-1 allele. Circulation. 2004, 110: 2204-2209. 10.1161/01.CIR.0000143835.95029.7DCrossRefPubMed
4.
Hadigan C, Meigs JB, Corcoran C, Rietschel P, Piecuch S, Basgoz N, Davis B, Sax P, Stanley T, Wilson PW, D'Agostino RB, Grinspoon S: Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis. 2001, 32: 130-139. 10.1086/317541CrossRefPubMed
5.
Rao A, D'Amico S, Balasubramanyam A, Maldonado M: Fenofibrate is effective in treating hypertriglyceridemia associated with HIV Lipodystrophy. Am J Med Sci. 2004, 327: 315-318. 10.1097/00000441-200406000-00003CrossRefPubMed
6.
Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V: Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987, 317: 1237-1245. 10.1056/NEJM198711123172001CrossRefPubMed
7.
Lee JW, Bajwa PJ, Carson MJ, Jeske DR, Cong Y, Elson CO, Lytle C, Straus DS: Fenofibrate represses interleukin-17 and interferon-gamma expression and improves colitis in interleukin-10-deficient mice. Gastroenterology. 2007, 133: 108-123. 10.1053/j.gastro.2007.03.113CrossRefPubMed
8.
Schulz C, Schäfer A, Stolla M, Kerstan S, Lorenz M, von Brühl ML, Schiemann M, Bauersachs J, Gloe T, Busch DH, Gawaz M, Massberg S: Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets. Circulation. 2007, 116: 764-773. 10.1161/CIRCULATIONAHA.107.695189CrossRefPubMed
9.
Cheng C, Tempel D, van Haperen R, de Boer HC, Segers D, Huisman M, van Zonneveld AJ, Leenen PJ, Steen van der A, Serruys PW, de Crom R, Krams : Shear stress-induced changes in atherosclerotic plaque composition are modulated by chemokines. J Clin Invest. 2007, 117: 616-626. 10.1172/JCI28180PubMedCentralCrossRefPubMed
10.
Simmons G, Reeves JD, Hibbitts S, Stine JT, Gray PW, Proudfoot AE, Clapham PR: Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands. Immunol Rev. 2000, 177: 112-126. 10.1034/j.1600-065X.2000.17719.xCrossRefPubMed
11.
Coll B, Alonso-Villaverde C, Parra S, Montero M, Tous M, Joven J, Masana L: The stromal derived factor-1 mutated allele (SDF1-3'A) is associated with a lower incidence of atherosclerosis in HIV-infected patients. AIDS. 2005, 19: 1877-1883. 10.1097/01.aids.0000183516.22266.ddCrossRefPubMed
Metadata
Title
Treatment of hypertriglyceridemia and HIV: fenofibrate-induced changes in the expression of chemokine genes in circulating leukocytes
Authors
Carlos Alonso-Villaverde
Gerard Aragonès
Raúl Beltrán-Debón
Laura Fernández-Sender
Anna Rull
Jordi Camps
Josep M Alegret
Jorge Joven
Publication date
01-12-2009
Publisher
BioMed Central
Published in
AIDS Research and Therapy / Issue 1/2009
Electronic ISSN: 1742-6405
DOI
https://doi.org/10.1186/1742-6405-6-26

Other articles of this Issue 1/2009

AIDS Research and Therapy 1/2009 Go to the issue

Research

Comparative study of the persistence of anti-HIV activity of deoxynucleoside HIV reverse transcriptase inhibitors after removal from culture

Review

Hypothesis of snake and insect venoms against Human Immunodeficiency Virus: a review

Short report

Effectiveness of antiretroviral therapy and development of drug resistance in HIV-1 infected patients in Mombasa, Kenya

Research

HLA-Cw*04 allele associated with nevirapine-induced rash in HIV-infected Thai patients

Research

RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models

Research

Antiretroviral activity of the aminothiol WR1065 against Human Immunodeficiency virus (HIV-1) in vitro and Simian Immunodeficiency virus (SIV) ex vivo
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits